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Antivirulence Therapy as an Alternative to
Antibiotics
Antibiotics are still critically important as a first line therapy for
the treatment of various bacterial infections in the clinic. In
addition to their use in human medicine, these compounds have
also been used for decades in animal production, for both growth
promotion and veterinary purposes [1,2]. Because of the
development and spread of antibiotic resistance, there is a growing
awareness that antibiotics should be used with more care [3], and
as a consequence, the development of alternative methods to
control pathogenic bacteria in animal production will be
important to ensure good productivity in the future.
Infection of both terrestrial and aquatic animals by bacterial
pathogens requires the production of different virulence factors,
i.e. gene products that allow the pathogenic bacteria to enter and
damage the host. Major virulence factors include gene products
involved in motility, adhesion, host tissue degradation, iron
acquisition, secretion of toxins, and protection from host defense
[4]. As virulence factors are required for infection, preventing
pathogens from producing them constitutes an interesting
alternative strategy for disease control, a strategy that has been
termed antivirulence therapy [5]. Antivirulence therapy is based
on a thorough understanding of the mechanisms by which
bacterial pathogens cause disease. In this respect, studies aimed
at understanding how bacteria cause disease have identified (and
will probably continue to do so) targets for therapeutics with
completely novel modes of action. Inhibitors of specific virulence
factors, such as secretion systems, have been reported in literature
[6]. However, considerably more research effort is being directed
towards interference with regulatory mechanisms that control the
expression of (multiple) virulence factors, such as bacterial cell-to-
cell communication (quorum sensing) and host-pathogen signalling
(Fig. 1). The following paragraphs will focus on interference with
these mechanisms as a novel strategy to control animal pathogens,
using Escherichia coli and Salmonella spp. as examples of pathogens
for terrestrial animals, and Aeromonas spp. and Vibrio spp. as
examples of aquatic pathogens.
Interfering with Bacterial Cell-to-Cell
Communication in Animal Pathogens
Quorum sensing, or bacterial cell-to-cell communication, is a
mechanism of gene regulation in which bacteria coordinate the
expression of certain genes in response to the presence of small
signal molecules. This regulatory mechanism has been shown to
control virulence gene expression in many different pathogens,
and a wide range of molecules (both of natural and synthetic
origin) able to interfere with quorum sensing systems have been
reported (for a recent review see [15]). Quorum sensing has been
documented to be required for full virulence of Aeromonas spp. and
vibrios towards different aquatic hosts, including fish and
crustaceans [16–18]; moreover, different quorum sensing-disrupt-
ing agents have been proven effective in controlling disease.
Effective compounds include cinnamaldehyde, brominated fur-
anones and brominated thiophenones [14], antagonistic acylho-
moserine lactones [7], and signal molecule-degrading enzymes
[11]. Virulence-related phenotypes (including motility and adhe-
sion) of E. coli and Salmonella spp. have also been reported to be
controlled by quorum sensing molecules [19,20], and the signal
molecule indole has been shown to affect killing of the nematode
C. elegans [21]. However, to the best of my knowledge, no reports
have been published thus far mentioning the successful use of
inhibitors of these types of bacterial cell-to-cell communication to
protect terrestrial farmed animals from disease caused by these
pathogens. The evaluation of these kind of compounds in
terrestrial animals should be rather straightforward, as many
inhibitors have been isolated and/or synthesised [15]. Although
the peptide quorum sensing systems of Gram-positive bacteria thus
far have received much less attention than acylhomoserine lactone
systems in Gram-negative bacteria, some inhibitors of these
systems have been documented as well (e.g. cyclic peptide
inhibitors of quorum sensing in staphylococci [22]), and these
kind of compounds might also prove effective in controlling animal
diseases caused by Gram-positive pathogens.
Interfering with Host-Pathogen Signalling in
Animal Pathogens
In addition to bacterial signals, E. coli and Salmonella spp. can
also sense and respond to host cues such as the catecholamine
stress hormones adrenaline and noradrenaline. These hormones
are an integral part of the acute ‘‘fight or flight’’ stress response in
animals and are conserved among vertebrates and invertebrates.
Catecholamines can facilitate the removal of iron from host iron-
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Figure 1. Simplified schematic representation of virulence regulatory systems based on detection of signal molecules in animal
pathogenic bacteria. These include (left) quorum sensing based on acylhomoserine lactones (AHL) and (right) quorum sensing in vibrios and
catecholamine stress hormone sensing. For each type of system, examples of natural ligands, receptor inhibitors, and other inhibiting agents are
shown. Dioxazaborocane is an inhibitor of AI-2 sensing in V. harveyi and LED209 is an inhibitor of catecholamine sensing in E. coli. The signal
transduction inhibitors are inhibitors of quorum sensing signal transduction in vibrios.
doi:10.1371/journal.ppat.1003603.g001
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binding proteins, thereby making it available to the bacteria and
increasing their growth under iron-limited conditions [23]. In
addition to their growth-stimulatory effect, catecholamines also
increase virulence gene expression of pathogenic bacteria. In
different pathogenic E. coli strains, the compounds have been
reported to affect the production of virulence-related phenotypes
such as motility and type III secretion [24], Shiga toxin expression
[25], and expression of pilus and fimbrial adhesins [26]. In
Salmonella spp., they have been reported to affect motility [27],
hemolysin production [28], type III secretion [10], and intestinal
colonization in chicks, pigs, and calves [29,30]. Different bacterial
adrenergic sensors have recently been described (with the best-
described one being QseC), showing different susceptibilities to
blocking with eukaryotic a- and b- adrenergic receptors,
respectively [31,32]. An inhibitor of bacterial catecholamine
sensing, LED209, has also been described [10]. It needs to be
noted that (at least in Salmonella spp.) different research groups
have reported conflicting effects of catecholamines, which may
reflect differences in host species, bacterial strains, routes of
infection, and nature of mutations [23,31,32]. Interestingly, vibrios
and Aeromonas spp. also respond to catecholamines, and QseC
homologues have been reported in these bacteria as well [33].
Advantages of this Strategy
When compared to the use of antibiotics, a major advantage of
antivirulence therapy is that there will be less interference with
non-target organisms (i.e. the commensal microbiota), as it
specifically targets virulence gene expression or virulence gene
regulation; in the latter case there might be some interference with
regulatory mechanisms in non-target organisms. Moreover,
because such a strategy will pose selective pressure only under
conditions in which the virulence genes are required, the tendency
towards resistance development and spread will probably also be
lower (though not absent) [34]. It should be noted, however, that
some of the resistance mechanisms that bacteria have acquired
during exposure to antibiotics can also render them resistant to
antivirulence agents. This was recently demonstrated in Pseudomo-
nas aeruginosa, in which clinical isolates showing an increased
expression of a multidrug efflux pump were also resistant to a
quorum sensing-disrupting brominated furanone [35]. A major
advantage of targeting the regulatory mechanisms described above
is that agents can be used that do not need to enter the cells to
exert their activity (e.g., signal molecule-degrading enzymes or
compounds that interfere with cell surface receptors). Conse-
quently, pre-existing nonspecific resistance mechanisms (e.g.
multidrug efflux pumps and decreased cell membrane permeabil-
ity) will not alter the effectiveness of such agents.
Conclusion
It is of significant interest to further develop antivirulence
therapy as a novel biocontrol strategy for animal production.
Further research is needed to document the impact of such a
strategy in different host-pathogen settings and to continue the
quest for novel antivirulence agents, i.e. inhibitors of either natural
or synthetic origin, or microorganisms able to interfere with
virulence (regulatory) mechanisms.
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